These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16170390)

  • 21. Comparative proteomic analysis of ductal and lobular invasive breast carcinoma.
    Oliveira NC; Gomig TH; Milioli HH; Cordeiro F; Costa GG; Urban CA; Lima RS; Cavalli IJ; Ribeiro EM
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative expressed sequence hybridization reveals differential gene expression in morphological breast cancer subtypes.
    Vanden Bempt I; Vanhentenrijk V; Drijkoningen M; De Wolf-Peeters C
    J Pathol; 2006 Mar; 208(4):486-94. PubMed ID: 16402338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An exceptional metaplastic lobular breast carcinoma diagnosed through exome sequencing.
    Bergeron A; Desmoulins I; Beltjens F; Causeret S; Charon-Barra C; Martin E; Richard C; Boidot R; Arnould L
    J Clin Pathol; 2020 Sep; 73(9):597-601. PubMed ID: 31980561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
    Dabbs DJ; Bhargava R; Chivukula M
    Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
    Berx G; Cleton-Jansen AM; Nollet F; de Leeuw WJ; van de Vijver M; Cornelisse C; van Roy F
    EMBO J; 1995 Dec; 14(24):6107-15. PubMed ID: 8557030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.
    Buerger H; Simon R; Schäfer KL; Diallo R; Littmann R; Poremba C; van Diest PJ; Dockhorn-Dworniczak B; Böcker W
    Mol Pathol; 2000 Jun; 53(3):118-21. PubMed ID: 10897329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.
    Aldaz CM; Chen T; Sahin A; Cunningham J; Bondy M
    Cancer Res; 1995 Sep; 55(18):3976-81. PubMed ID: 7664266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
    Berx G; Cleton-Jansen AM; Strumane K; de Leeuw WJ; Nollet F; van Roy F; Cornelisse C
    Oncogene; 1996 Nov; 13(9):1919-25. PubMed ID: 8934538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles.
    Bertucci F; Orsetti B; Nègre V; Finetti P; Rougé C; Ahomadegbe JC; Bibeau F; Mathieu MC; Treilleux I; Jacquemier J; Ursule L; Martinec A; Wang Q; Bénard J; Puisieux A; Birnbaum D; Theillet C
    Oncogene; 2008 Sep; 27(40):5359-72. PubMed ID: 18490921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
    Sarrió D; Moreno-Bueno G; Hardisson D; Sánchez-Estévez C; Guo M; Herman JG; Gamallo C; Esteller M; Palacios J
    Int J Cancer; 2003 Aug; 106(2):208-15. PubMed ID: 12800196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of E-cadherin in low-grade ductal breast tumourigenesis.
    Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I
    J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
    Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
    Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.
    Huiping C; Jonasson JG; Agnarsson BA; Sigbjornsdottir BI; Huebner K; Ingvarsson S
    Eur J Cancer; 2000 Aug; 36(12):1552-7. PubMed ID: 10930803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ductal and lobular preneoplasia: role in breast cancer development].
    Aulmann S
    Pathologe; 2011 Nov; 32 Suppl 2():316-20. PubMed ID: 21915665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Expression Analysis Identifies Common and Distinct Signatures Underlying Ductal and Lobular Breast Cancers.
    Huang Q; Liu J; Chen T; Li L; Wang L; Wu Y
    J Reprod Med; 2017; 62(5-6):271-83. PubMed ID: 30027719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.